what's the difference between bpc 157 and 159 BPC-157 Explained: Benefits, Safety & Oral vs Injectable Options PANKAJ KAINTH CLASSES on Instagram

Most commonly, doctors will prescribe it for the following health conditions: Growth hormone deficiency According to a 2012 review published in BioDrugs , sermorelins primary therapeutic use has been to diagnose growth hormone deficiency .9 With a normally functioning pituitary gland, a patients growth hormone levels should reach a peak value within a specific time frame after sermorelin administration

Why Metabolic Safety Matters Full-length human growth hormone therapy carries well-documented metabolic risks including IGF-1 elevation, impaired glucose tolerance, and increased diabetes risk

Then they gave BPC-157

NICE recommends that: Pharmacological treatment should only be used as part of a comprehensive weight management programme Medications should be prescribed only when licensed and evidence-based Very low-calorie diets (VLCDs, 800 kcal/day) may be considered for specific patients under specialist supervision, but should be time-limited and nutritionally complete Wegovy is recommended by NICE (TA875) for specific patient groups: adults with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities), who have at least one weight-related comorbidity and have completed a tier 3 service

Unlike most nutrients, B12 requires a protein called intrinsic factor (IF) to be absorbed

This property underlies its use as a redox probe in chemical and biological research, including electron transport chain assays and mitochondrial function studies (Nedu et al